BR9404004A - Isolated polypeptide antigen fragment derived or analogous nucleic acid molecule method to reduce the spread of a helminthic parasite and vaccine composition - Google Patents

Isolated polypeptide antigen fragment derived or analogous nucleic acid molecule method to reduce the spread of a helminthic parasite and vaccine composition

Info

Publication number
BR9404004A
BR9404004A BR9404004A BR9404004A BR9404004A BR 9404004 A BR9404004 A BR 9404004A BR 9404004 A BR9404004 A BR 9404004A BR 9404004 A BR9404004 A BR 9404004A BR 9404004 A BR9404004 A BR 9404004A
Authority
BR
Brazil
Prior art keywords
spread
nucleic acid
reduce
acid molecule
isolated polypeptide
Prior art date
Application number
BR9404004A
Other languages
Portuguese (pt)
Inventor
Andrew Richard Milner
Michael Panaccio
Terence William Spithill
Gene Louis Wijffels
Original Assignee
Daratech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daratech Pty Ltd filed Critical Daratech Pty Ltd
Publication of BR9404004A publication Critical patent/BR9404004A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
BR9404004A 1993-02-05 1994-02-04 Isolated polypeptide antigen fragment derived or analogous nucleic acid molecule method to reduce the spread of a helminthic parasite and vaccine composition BR9404004A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL710993 1993-02-05
PCT/AU1994/000051 WO1994017820A1 (en) 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same

Publications (1)

Publication Number Publication Date
BR9404004A true BR9404004A (en) 1999-05-25

Family

ID=3776688

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9404004A BR9404004A (en) 1993-02-05 1994-02-04 Isolated polypeptide antigen fragment derived or analogous nucleic acid molecule method to reduce the spread of a helminthic parasite and vaccine composition

Country Status (8)

Country Link
EP (1) EP0647138A4 (en)
JP (1) JPH07505787A (en)
AU (1) AU5996294A (en)
BR (1) BR9404004A (en)
CA (1) CA2126455A1 (en)
NO (1) NO942360L (en)
NZ (1) NZ261279A (en)
WO (1) WO1994017820A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9407614A (en) * 1993-09-28 1997-01-14 Univ Melbourne Putative protective antigens or fragments thereof against circumcinced trichostrongylus colubriformis and fasciola hepatica process to prepare an antigen associated with a disease pathogen selected from species fasciola ostertagia and trichostrongylus process to prepare a monoclonal antibody monoclonal antibody process to prepare antigenic diagnostic polypeptide kit to prevent disease in animals process for treating disease in animals
CA2284110C (en) * 1997-03-11 2012-08-28 Stichting Dienst Landbouwkundig Onderzoek An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
CA2425829A1 (en) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Proteases
ES2629602T5 (en) 2002-09-11 2021-06-08 Genentech Inc Protein purification
PL201419B1 (en) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Chimeric protein, sequence, construction, vegetable cell, method of obtaining chimeric protein and transgenic plant, transgenic plant, application of transgenic plant and chimeric protein
PL196114B1 (en) * 2002-12-31 2007-12-31 Inst Biotechnologii I Antybiot Inclusion bodies as antigenes in oral immunization of animals
WO2011043962A2 (en) * 2009-10-07 2011-04-14 Wyeth Llc Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
ES2525106B1 (en) * 2013-06-17 2015-09-29 Universidad De Salamanca Synthetic peptide derived from Fasciola hepatica and its use as a vaccine
GB201714057D0 (en) * 2017-09-01 2017-10-18 Univ College Dublin Nat Univ Of Ireland Dublin A fasciola hepatica antigen and vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
AU7871987A (en) * 1986-08-18 1988-03-08 Australian National University, The Helminth parasite vaccine
AU634754B2 (en) * 1989-01-31 1993-03-04 Daratech Pty Ltd Vaccine for the preventative treatment of infection of liver fluke in ruminants
JP2700088B2 (en) * 1991-07-25 1998-01-19 房則 濱島 Immunosuppressants
ATE240397T1 (en) * 1992-10-21 2003-05-15 John Pius Dalton VACCINE CONTAINING THIOL PROTEASE

Also Published As

Publication number Publication date
NO942360D0 (en) 1994-06-21
JPH07505787A (en) 1995-06-29
AU5996294A (en) 1994-08-29
EP0647138A1 (en) 1995-04-12
NZ261279A (en) 1996-03-26
WO1994017820A1 (en) 1994-08-18
NO942360L (en) 1994-10-05
EP0647138A4 (en) 1996-03-06
CA2126455A1 (en) 1994-08-06

Similar Documents

Publication Publication Date Title
PT90312A (en) A method for the preparation of novel recombinant and chemokine antibodies directed against a human adenocarcinoma antigen
BR8906988A (en) TETRAPIPTIDIO, PEPTIDE, PHARMACEUTICAL COMPOSITION, PROCESS FOR USE OF PEPTIDE AND REAGENT FOR DIAGNOSIS
BR9407738A (en) Composition of hair conditioning shampoo and process for the preparation of a conditioning shampoo
DK0732936T3 (en) Adjuvant to antigens, method of preparation and use
BR9005700A (en) INSECTICIDE AND / OR ACARICIDE AND / OR NEMATICIDE COMPOSITION AND PROCESS FOR ITS PREPARATION
BR9404004A (en) Isolated polypeptide antigen fragment derived or analogous nucleic acid molecule method to reduce the spread of a helminthic parasite and vaccine composition
BR9106159A (en) SYNTHETIC POLYPEPTIDE, VACCINE, CASE TO DETECT HIV OR HIV ANTIBODIES, DNA MOLECULE, PHARMACEUTICAL COMPOSITION, ANTIBODY OR FRAGMENT OF THE SAME ANTIGEN, THERAPY PROCESSES OR HIV INFECTION, PROTECTING HIV AND HIV INFECTION, PROTECTING HIV THE MANUFACTURE OF A SYNTHETIC POLYPEPTIDE, PHARMACEUTICAL COMPOSITION AND AN ANTIBODY OR BINDING FRAGMENT OF THE SAME
BR9508714A (en) Compound process for preparing streptograms by muta-synthesis nucleotide sequence recombinant DNA vector use of a mutant strain sequence and / or polypeptide vector and pharmaceutical composition
BR9406348A (en) Composition and process for detecting a binder and the presence or quantity of it
BR8905349A (en) PROCESS FOR THE PREPARATION OF A CYCLEALCANONE AND / OR A CYCLEALCANOL
BR9709958A (en) Polypeptides capable of forming antigen binding structures with specificity for the rhesus antigens in the dna that encodes them and the process for their preparation and use
BR8606969A (en) PERFLUOROPOLIETERS AND PROCESS OF PREPARATION OF THE SAME AND PERFLUOROPOLIMETHYLENE OXIDE
CA2190515A1 (en) Vaccine against mycobacterial infections
IT1217860B (en) NAIL PAINTS FOR NAILS AND RELATED PACKAGING
EE9800334A (en) Nucleic and amino acid sequences associated with Helicobacter pylor and vaccine compositions derived therefrom
BR9200697A (en) MONOCLINE ZIRCON OXIDE, PROCESS FOR ITS PREPARATION AND APPLICATION
BR9301448A (en) COMPOSITION AND PROCESS FOR ITS PREPARATION
BR8906507A (en) RARE EARTH OXIDE AND PROCESS FOR ITS PREPARATION
PT90976A (en) PROCESS FOR THE PREPARATION OF PROTEINS AND NUCLEIC ACIDS
BR9708979A (en) Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein
EP0293827A3 (en) Assay for leishmaniasis
PT95645A (en) Process for the preparation of a sweetening agent derived from L-aspartic acid or 1-glutamic acid
ITMI931828A0 (en) PROCESS FOR THE PREPARATION OF PENTAFLUOROETHANE
BR9302359A (en) COMPOUND, PROCESS FOR ITS PREPARATION, MEDICINE AND USE
BR8806266A (en) PREPARATION PROCESS FOR ALUMINUM OXIDE GRANULATES AND PRODUCTS SO OBTAINED

Legal Events

Date Code Title Description
FA7 Application withdrawn (art. 18 par. 1 of law 5772/71) - being contrary to morals, good customs and public security, order and health